Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17325374 | 0.82 | OGG1 (0.31) | — | |
| SCHEMBL17325372 | 0.75 | — | — | |
| SCHEMBL538319 | 0.74 | TP53 (0.38) | SRC | |
| SCHEMBL155452 | 0.71 | MGLL (0.35) | — | |
| SCHEMBL17924891 | 0.71 | MGLL (0.35) | — | |
| SCHEMBL932564 | 0.69 | CSNK2A2 (0.48) | — | |
| SCHEMBL43717 | 0.69 | CSNK2A2 (0.48) | — | |
| SCHEMBL15318993 | 0.69 | CSNK2A2 (0.48) | — | |
| SCHEMBL10049944 | 0.67 | PMP22 (0.32) | — | |
| SCHEMBL28981240 | 0.67 | CSNK2A2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9498541-B2 | Cross-linkers and their uses | IMMUNOGEN, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150352223-A1 | CROSS-LINKERS AND THEIR USES | IMMUNOGEN, INC. | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150352223-A1 | CROSS-LINKERS AND THEIR USES | MTCL3, DCLRE1A, PCNA | SRC 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.